Related Experiment Video
Updated: Aug 23, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
Plasma human growth cytokines in children with vasovagal syncope
Yuanyuan Wang1, Yaru Wang1, Bing He2
1Department of Pediatrics, Peking University First Hospital, Beijing, China.
Insights
Plasma human growth cytokines are altered in pediatric vasovagal syncope (VVS). Elevated hepatocyte growth factor (HGF) and insulin-like growth factor binding protein-1 (IGFBP-1), with decreased epidermal growth factor (EGF), are linked to VVS development and diagnosis.
Area of Science:
- Pediatric Cardiology
- Endocrinology
- Biochemistry
Background:
- Vasovagal syncope (VVS) is a common cause of syncope in children.
- The underlying pathophysiological mechanisms of VVS are not fully understood.
- Growth factors play crucial roles in various physiological processes and may be implicated in VVS.
Purpose of the Study:
- To investigate the profile of plasma human growth cytokines in children with VVS.
- To identify specific growth factors associated with the development of pediatric VVS.
- To evaluate the diagnostic potential of these growth factors for VVS.
Main Methods:
- Plasma samples from VVS children and healthy controls were analyzed using cytokine arrays.
- Discovery and validation sets were employed to identify and confirm differential cytokine levels.
- Statistical analyses, including hierarchical clustering, logistic regression, and ROC curve analysis, were performed.
Main Results:
- Children with VVS showed altered plasma levels of several growth factors compared to controls.
- Significantly higher concentrations of hepatocyte growth factor (HGF) and insulin-like growth factor binding protein-1 (IGFBP-1) were observed in VVS patients.
- Lower concentrations of epidermal growth factor (EGF) were found in pediatric VVS patients.
Conclusions:
- Plasma human growth cytokine profiles are altered in pediatric VVS.
- Elevated HGF and IGFBP-1, and decreased EGF are associated with pediatric VVS development.
- These three proteins show potential as diagnostic biomarkers for pediatric VVS.
Purpose:
The study was designed to investigate the profile of plasma human growth cytokines in pediatric vasovagal syncope (VVS).
Materials And Methods:
In the discovery set of the study, plasma human growth cytokines were measured using a Quantiboby Human Growth Factor Array in 24 VVS children and 12 healthy controls. Scatter and principal component analysis (PCA) diagrams were used to describe the samples, an unsupervised hierarchical clustering analysis was used to categorize the samples. Subsequently, the cytokines obtained from the screening assays were verified with a suspension cytokine array in the validation set of the study including 53 VVS children and 24 controls. Finally, the factors associated with pediatric VVS and the predictive value for the diagnosis of VVS were determined.
Results:
In the discovery study, the differential protein screening revealed that the plasma hepatocyte growth factor (HGF), transforming growth factor b1 (TGF-b1), insulin-like growth factor binding protein (IGFBP)-4, and IGFBP-1 in children suffering from VVS were higher than those of the controls (all adjust P- value < 0.05). However, the plasma IGFBP-6, epidermal growth factor (EGF), and IGFBP-3 in pediatric VVS were lower than those of the controls (all adjust P- value < 0.01). Meanwhile, the changes of 7 differential proteins were analyzed by volcano plot. Unsupervised hierarchical cluster analysis demonstrated that patients in the VVS group could be successfully distinguished from controls based on the plasma level of seven differential proteins. Further validation experiments showed that VVS patients had significantly higher plasma concentrations of HGF, IGFBP-1, and IGFBP-6, but lower plasma concentrations of EGF and IGFBP-3 than controls. The logistics regression model showed that increased plasma concentration of HGF and IGFBP-1 and decreased plasma concentration of EGF were correlated with the development of pediatric VVS. ROC curve analysis showed that the abovementioned 3 proteins were useful for assisting the diagnosis of VVS.
Conclusion:
Plasma human growth cytokine profiling changed in pediatric VVS. Elevated plasma concentrations of HGF and IGFBP-1, and decreased EGF were associated factors in the development of pediatric VVS. The abovementioned three proteins are helpful for the diagnosis of pediatric VVS.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Pathophysiology of Vomiting
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Vascular Spasm
Cardiopulmonary Resuscitation IV: Pharmacological Management
Regulation of Angiogenesis and Blood Supply

